Vertebrates are highly sensitive to both retinoic acid (RA) deficiency
and excess. The RA signal is thought to be transduced by nuclear rece
ptors (the RAR and RXR families) which activate the expression of targ
et genes via cis-acting transcriptional enhancer elements. Each of the
three RAR genes, RAR alpha, RAR beta, and RAR gamma, gives rise to se
veral isoforms by differential usage of two promoters and alternative
splicing. RAR beta 2 is the most abundant of the four RAR beta isoform
s, and its transcription is spatially and temporally restricted in dev
eloping embryos, suggesting that it might perform specific functions.
Furthermore, RAR beta 2 expression can be induced via a retinoic acid
response element located in its promoter region. This RA effect is par
ticularly interesting since under conditions of RA excess, RAR beta 2
promoter activity and transcript accumulation are induced in regions o
f developing embryos in which malformations subsequently appear, such
as the craniofacial region, the hindbrain, and the limbs. These findin
gs have led to the suggestion that the RAR beta 2 isoform might mediat
e some of the teratogenic effects of RA. In this study, we have elimin
ated RAR beta 2 expression by targeted gene disruption. RAR beta 2 nul
l mutants exhibit an apparently normal phenotype, indicating that othe
r RARs must compensate for RAR beta 2 sufficiently well to allow norma
l prenatal and postnatal development to proceed. By challenging RAR be
ta 2 null embryos with teratogenic doses of RA, we have also directly
addressed the question of whether RAR beta 2 is required for mediating
RA-induced malformations. (C) 1994 Academic Press, Inc.